Gilead Sciences to Present at Upcoming Investor Conferences
Get Alerts GILD Hot Sheet
Join SI Premium – FREE
FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:
- TD Cowen Annual Health Care Conference on Tuesday, March 4 at 11:10 AM Eastern Time
- Leerink Partners Global Healthcare Conference on Tuesday, March 11 at 10:40 AM Eastern Time
The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250219400385/en/
Jacquie Ross, CFA – Investors
[email protected]
Source: Gilead Sciences, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Norton Manx R Earns Landmark International Design Excellence Award for Reimagining the Superbike
- Pump.Fun Price Prediction: Memecoin Traders Buy MemeToro and PUMP For Upcoming Crypto Bull Run
- 40 Acres And A Profit Launches The Levi Bean Lake Real Estate Course Built on Real Houses and $1M+ in Capital
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Twitter, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share